About Embio Limited
Data last updated:
Embio Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Malladi Industries Private Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 20 January 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH1986PLC038680. Its GSTIN is 27AAACE1154C1Z9 (Maharashtra). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹43.62 Cr and a paid-up capital of ₹4.7 Cr. It was formerly known as Emmellen Biotech Pharmaceuticals Ltd. It is led by directors including Devesh Malladi (Managing Director) and Madhusudan Rao Garimella.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 501 Sentinel 5th Floor Hiranandani Gardens Powai, Mumbai, Maharashtra, India – 400076.
As per the financials filed for FY 2025, the company reported a revenue of ₹274.76 Cr, a growth of 49% compared to the previous year. For the same year it recorded a net profit of ₹39.06 Cr (net margin 14.2%) and EBITDA of ₹70.85 Cr (EBITDA margin 25.8%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 10% over five years.
The company has about 700 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Embio. As per MCA filings, the company has open charges of ₹66.03 Cr and satisfied charges of ₹109.3 Cr on record. Court records list 57 cases involving the company, including 32 filed by the company and 26 filed against it; 6 cases are pending. The company has 8 deals on record (7 secondary share transfers, 1 funding round), with disclosed funding of ₹2.15 Cr; the latest was in March 2025. The company has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 51 overdue payments to 22 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website embio.co.in.
Company details
CIN history
Embio has one previous CIN (Corporate Identification Number): L24110MH1986PLC038680. The current CIN is U24110MH1986PLC038680, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24110MH1986PLC038680 | Current |
| L24110MH1986PLC038680 | Previous |
Contact details
Embio Limited's registered office is in Mumbai, Maharashtra. Its website is embio.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address501 Sentinel 5th Floor Hiranandani Gardens Powai, Mumbai, Maharashtra, India – 400076
- IndustryPharma, API Manufacturers
To see the full contact details of Embio Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Embio operates one associated brand: Embio. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| APIs and chiral intermediates are manufactured by Embio under contract. | embio.co.in |
Business activity
The main business activity of Embio is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Embio Limited, buy the company report.
Financials of Embio Limited
FY 2025 filings availableEmbio Limited reported revenue of ₹274.76 Cr (up 49% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 49% growth in the latest year. EBITDA rose 214% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹274.76 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹70.85 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹39.06 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 25.8% | ||||
| Net Profit Margin | 14.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Embio Limited, buy the company report.
Board of directors of Embio Limited
Embio has 5 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhusudan Rao Garimella | Director | 07 Aug 2017 | 9 Years 3 Months | Current |
| Ajit Tekchand Vaswani | Director | 16 Oct 2001 | 25 Years 0 Months | Current |
| Devesh Malladi | Managing Director | 01 Oct 2007 | 19 Years 1 Months | Current |
| Raghavachari Kasthuri Rangan Also directs: Aptia Group India Private Limited | Director | 20 Sep 2024 | 2 Years 1 Months | Current |
| Aadya Malladi | Additional Director | 26 Jun 2025 | 1 Years 4 Months | Current |
Auditor
Embio Limited is audited by SSPA & Associates Chartered Accounts for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SSPA & Associates Chartered Accounts | FY 2025 | 131069W |
Shareholding
The shareholding of Embio Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Embio Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Mar 2022 | 100554671 | Axis Bank Limited | ₹25 Cr | Open | |
| 10 Dec 2012 | 10394806 | Biotechnology Industry Research Assistance Council | ₹2 Cr | Open | |
| 03 Dec 2002 | 80046613 | Axis Bank Limited | ₹25 Cr | Open | |
| 28 Jun 1995 | 90219644 | State Bank of India | ₹14.03 Cr | Open | |
| 28 May 2015 | 10576125 | Hdfc Bank Limited | ₹30 Lakh | Satisfied |
To see the full charge records of Embio Limited, buy the company report.
Total charge records: 33 View all charges
Deals & funding
Embio Limited has 8 deals on record (7 secondary share transfers, 1 funding round), with disclosed funding of ₹2.15 Cr; the latest was in March 2025.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2025 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| May 2019 | Secondary share transfer | Undisclosed | Seller: M Devesh HUF, an individual |
| Dec 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Nov 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: M Devesh HUF, an individual |
| Oct 2011 | Secondary share transfer | Undisclosed | Buyer: Malladi Industries Private Limited , an individual Seller: Malladi Investments Private Limited, Guru Narayan Fincap Private Limited , Urav Consultancy Private Limited , an individual |
To see the full deal history of Embio Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Embio Limited has 57 court cases on record: 32 filed by Embio, 26 filed against it. 6 cases are pending and 51 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 34 | 15 | 4 |
| District courts | 22 | 11 | 2 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 57)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Raigad, Maharashtra | Civil suit | Filed against the company by Jytra Technology Solutions Pvt Ltd Represented by Rraj Singh and Other 022 and 1 other | Pending |
| High Court, TAMIL NADU | Court case ((T)OP(PT)) | Filed by the company against Malladi Drugs and Pharmaceuticals Ltd. and 1 other | Disposed |
| High Court, MAHARASHTRA | Arbitration matter | Filed by the company against Rochem Separation Systems Pvt. Ltd. | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed by the company against Twentyone Sugars Ltd and Ors and 6 others | Disposed |
| District court, MANDYA, Karnataka | Court case (Ref) | Filed against the company by Embio Ltd., Mandya and 1 other | Disposed |
To see the full case history of Embio Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Embio Limited was last rated by Care on 10 Oct 2025.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 10 Oct 2025 |
To see the full credit ratings and regulatory alerts of Embio Limited, buy the company report.
MSME payment delays
Embio Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 51 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 22)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Als Testing Services India Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Clean Foot Corporation |
To see the full MSME payment records of Embio Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Embio Limited has a workforce of 700 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 700 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Embio Limited, buy the company report.
GST
Embio has 4 GST registrations: 4 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACE1154C1Z9 | Maharashtra | Active | 01 Jul 2017 |
| 27AAACE1154C2Z8 | Maharashtra | Active | 01 Apr 2025 |
| 29AAACE1154C1Z5 | Karnataka | Active | 01 Jul 2017 |
| 24AAACE1154C1ZF | Gujarat | Active | 09 Feb 2018 |
To see the full GST registrations and return filing status of Embio Limited, buy the company report.
Recent activity
Embio Limited has 14 board changes on record since 2001: 6 appointments and 8 cessations. The latest: Aadya Malladi was appointed as Additional Director on 26 Jun 2025.
82 earlier events are in the company report.
Frequently asked questions
Embio is an active public limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 20 January 1986 (40+ years old) and is registered under CIN U24110MH1986PLC038680.
Embio has 5 current directors:
- Devesh Malladi - Managing Director
- Madhusudan Rao Garimella - Director
- Ajit Tekchand Vaswani - Director
- Raghavachari Kasthuri Rangan - Director
- Aadya Malladi - Additional Director
The latest financial statements of Embio on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Embio is 27AAACE1154C1Z9, registered in Maharashtra. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 27AAACE1154C2Z8 (Maharashtra), 29AAACE1154C1Z5 (Karnataka), 24AAACE1154C1ZF (Gujarat).
The CIN (Corporate Identification Number) of Embio is U24110MH1986PLC038680. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Embio has 57 court cases on record: 32 filed by the company and 26 filed against it. 6 are pending. Most are in the high courts.
Embio was incorporated on 20 January 1986, making it 40+ years old. It is registered with the Registrar of Companies, Mumbai.
Embio has 8 deals on record (7 secondary share transfers, 1 funding round), with disclosed funding of ₹2.15 Cr; the latest was in March 2025.
Aadya Malladi was appointed as Additional Director on 26 Jun 2025. Hanumant Avadhani Malladi ceased to be Director on 30 Sep 2024. Raghavachari Kasthuri Rangan ceased to be Additional Director on 26 Sep 2024. Embio has 14 board changes on record in total.
Embio has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 51 overdue payments to 22 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Embio can be reached through the website embio.co.in. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
